Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Akums Drugs & Pharmaceuticals
Add new alert
AKUMS •
NSE
Akums Drugs & Pharmaceuticals
₹547.30
3.60 (0.66%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
ScoutQuest •
2 weeks ago
Akums Drugs sees descending channel breakout with MACD bullish crossover. SMA rising, breakout volume high, bullish weekly candle observed.
ScoutQuest •
3 weeks ago
ICRA reaffirms Akums Drugs' long-term rating at AA (Stable) and short-term at A1. Ratings reflect strong CDMO growth, low debt, and liquidity; challenges include competition, raw material costs.
BSE •
3 weeks ago
Akums Drugs and Pharmaceuticals Ltd's credit ratings were reaffirmed by ICRA for working capital limits (AA/Stable, A1) and assigned for a Rs. 200 crore commercial paper program (A1). ADPL's CDMO revenue grew 7% YoY to Rs. 2,533 crore in 9M FY26, supported by volume growth and a EUR 100M contract boosting liquidity.
ScoutQuest •
4 weeks ago
Akums Drugs and Pharmaceutical sees breakout from descending resistance trendline. The stock shows higher lows, weekly consolidation, and volume spike indicating accumulation.
Business Standard •
2 months ago
Indian CDMOs, including SAI Life Sciences and Akums Drugs, expand capacity as demand for complex drug development rises. Global pharma firms increasingly outsource complex drug work, driving tech investments in Indian CDMOs.
Livesquawk •
3 months ago
Akums Drugs plans to launch two injectable blocks by Q4 2026. The company targets 50% utilization in year one, boosting 2027 revenues.
BSE •
3 months ago
Akums Drugs reports strong Q3FY26 results with 14.8% YoY revenue growth and 21% EBITDA rise. CDMO revenue grew 16.3% YoY; API pricing softness stabilized, aiding margin improvement.
ScoutQuest •
3 months ago
Akums Drugs' board approved Q3 and 9M Dec 2025 unaudited financials. Recognized ₹38.1M exceptional item due to labor law impact; IPO proceeds used for growth.
MarketScreener •
3 months ago
Akums Drugs reported a Q3 consolidated net profit of ₹663.2M.
BSE •
3 months ago
Akums Drugs to hold board meeting on 13 Feb 2026 to approve Q3 and 9M FY25 results.